
Tamisol D0.4 mg+0.5
Healthcare Pharmaceuticals Ltd.
Tamsulosin Hydrochloride + Dutasteride is a fixed-dose combination of an alpha-1 adrenergic receptor antagonist (tamsulosin) and a 5-alpha reductase inhibitor (dutasteride).
Tamsulosin Hydrochloride + Dutasteride is a fixed-dose combination of an alpha-1 adrenergic receptor antagonist (tamsulosin) and a 5-alpha reductase inhibitor (dutasteride).
Tamsulosin Hydrochloride + Dutasteride is not approved or indicated for the prevention of prostate cancer, and it is not indicated for use in women or children.
| Population | Dose | Frequency |
|---|---|---|
| Adult men with symptomatic BPH | One capsule (dutasteride 0.5 mg / tamsulosin HCl 0.4 mg) | Once daily, approximately 30 minutes after the same meal each day |
No dose adjustment is required in patients with renal impairment; Tamsulosin Hydrochloride + Dutasteride has not been studied in patients with end-stage renal disease.
No dose adjustment is established for mild-to-moderate hepatic impairment; use in patients with severe hepatic impairment has not been studied and is not recommended (see Contraindications).
The most common adverse effects reported with Tamsulosin Hydrochloride + Dutasteride relate to its sexual, hemodynamic, and endocrine effects:
Tamsulosin Hydrochloride + Dutasteride is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.